Luke Dixon1,2,3,4,5,6, James Varley1,2,3,4,5,6, Anastasia Gontsarova1,2,3,4,5,6, Dermot Mallon1,2,3,4,5,6, Francesca Tona1,2,3,4,5,6, David Muir1,2,3,4,5,6, Asad Luqmani1,2,3,4,5,6, I H Jenkins1,2,3,4,5,6, Richard Nicholas1,2,3,4,5,6, Brynmor Jones1,2,3,4,5,6, Alex Everitt1,2,3,4,5,6
1Centre for Neuroinflammation and Neurodegeneration (R.N.), Faculty of Medicine, Imperial College London
2Department of Hematology (A.L.), Imperial College Healthcare NHS Trust
3Department of Neurosciences (J.V., I.H.J., A.E.), Imperial College Healthcare NHS Trust
4Department of Visual Neuroscience (R.N.), UCL Institute of Ophthalmology, London, United Kingdom.
5From the Department of Imaging (L.D., A.G., D. Mallon, F.T., B.J.), Imperial College Healthcare NHS Trust; Department of Neurosciences (J.V., I.H.J., A.E.), Imperial College Healthcare NHS Trust; Northwest London Pathology (D. Muir); Department of Hematology (A.L.), Imperial College Healthcare NHS Trust; Centre for Neuroinflammation and Neurodegeneration (R.N.), Faculty of Medicine, Imperial College London; and Department of Visual Neuroscience (R.N.), UCL Institute of Ophthalmology, London, United...
6Northwest London Pathology (D. Muir)
